Immunome Surges On News Of Merger With Morphimmune
Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.
Clayb Siegall Redmile Group Immunome Inc Enavate Sciences Targeted Effector Platform Discovery Engine
Source: rttnews.com